Contemporary management of epilepsy in pregnancy

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 40, Issue 4, 2000, Pages 413-415

  O'Brien, T J ^a   Vajda, F J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; ESTROGEN; ETHOSUXIMIDE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; LIVER ENZYME; ORAL CONTRACEPTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLASMA PROTEIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANENCEPHALUS; ARTICLE; AUSTRALIA; BIRTH DEFECT; COGNITIVE DEFECT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FEMALE; FETUS MORTALITY; HUMAN; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; MICROCEPHALY; NEURAL TUBE DEFECT; PATIENT CARE; POLYPHARMACY; PREGNANCY DISORDER; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SPINA BIFIDA; SPONTANEOUS ABORTION; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

EID: 0033670722     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2000.tb01171.x     Document Type: Article

References (35)

1. Are anti-epileptic drugs harmful when given during pregnancy?
2. Anticonvulsant drugs and congenital anomalies
3. Fetal hydantoin syndrome: Current status
4. Epilepsy and pregnancy: A report from the Oxford Record Linkage Study
5. Maternal epilepsy and abnormalities of the fetus and newborn
6. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epidemiologic and experimental findings spanning three decades; 2: Human studies
7. Pregnancy with epilepsy - A retrospective analysis
8. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy
9. Anticonvulsants and congenital malformations
10. Pregnancy and epilepsy: A retrospective study of 151 pregnancies
11. Pregnancies of women with epilepsy: A population-based study in Iceland
12. The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in children of epileptic parents
13. Congenital malformations (Second of two parts)
14. Minor anomalies in children of mothers with epilepsy
15. Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan
16. The course and outcome of pregnancy in women with epilepsy
17. Psychomotor development in children of mothers with epilepsy
18. The new antiepileptic drugs and women: Efficacy, reproductive health, pregnancy, and fetal outcome
19. Guidelines: For the care of women of childbearing age with epilepsy
20. Medical management of epilepsy. Consensus Statements
21. Guidelines for the care of women with epilepsy
22. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
23. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
24. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia
25. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
26. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
27. Neural tube defects and periconceptional folic acid in England and Wales: Retrospective study
28. Prevention of neural-tube defects with folic acid in China China-U.S. Collaboration Neural Tube Defect Prevention
29. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs
30. Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate
31. Major birth malformations and antiepileptic drugs
32. Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapy
33. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort
34. Teratogenicity of anticonvulsant drugs II: A prospective study
35. Epilepsy and pregnancy: A study of seizure frequency and patients demographics